Marie McAvoy, a former executive at GlaxoSmithKline Plc, has been named chief scientific officer at NanoSyrinx Ltd, a discovery stage biotech company based at the University of Warwick’s Medical School in the UK. At GSK she was senior director in the oncology cell therapy research unit. In her new job, she will help NanoSyrinx advance its ‘nanosyringe’ peptide and protein delivery technology for biologics. Dr McAvoy has worked in drug discovery for more than 20 years including in the fields of vaccines, biopharmaceuticals, and cell and gene therapies.
NanoSyrinx announced the appointment on 10 March 2022.
Copyright 2022 Evernow Publishing Ltd